Zauli D, Deleonardi G, Foderaro S, Grassi A, Bortolotti R, Ballardini G, Bianchi F B
Department of Internal Medicine, Cardioangiology, and Hepatology, University of Bologna, Italy.
Allergy Asthma Proc. 2001 Mar-Apr;22(2):93-5. doi: 10.2500/108854101778250625.
A subset of patients with idiopathic chronic urticaria (CU) has been recently classified as autoimmune on the basis of two main findings: association with thyroid autoimmunity and with anti-IgE and/or anti-IgE receptor antibodies. The association of CU with thyroid autoimmunity has been known since 1983, but its frequency varies in different reports. The objective of the present study was to verify the prevalence of thyroid antibodies (anti-thyroid peroxidase, TPO; thyroglobulin, TG; TSH-receptor, TSH-R) in two distinct series of CU: of known cause (70 cases, group A) and idiopathic (52 cases, group B). Twenty-three patients (M/F:7/16) of group A (33%) and 12 (M/F:4/8) of group B (23%) tested positive for at least one type of thyroid antibody. The difference was not statistically significant. Thyroid disease or altered serum TSH levels (requiring treatment) were present in 39% of group A and 42% of group B seropositive patients. In conclusion, the present study shows that CU, either of known cause or idiopathic, is more common in females than in males and is significantly associated with thyroid autoimmunity. These results were not expected on the assumption that autoimmune phenomena are a specific pattern of idiopathic CU. Thus, screening for thyroid autoimmunity and function is advisable in all patients with CU for the early identification of patients requiring either treatment of underlying thyroid dysfunction or follow-up.
基于两项主要发现,一部分特发性慢性荨麻疹(CU)患者最近被归类为自身免疫性疾病:与甲状腺自身免疫以及抗IgE和/或抗IgE受体抗体相关。自1983年以来,人们就已经知道CU与甲状腺自身免疫之间的关联,但其发生率在不同报告中有所不同。本研究的目的是验证两组不同的CU患者中甲状腺抗体(抗甲状腺过氧化物酶,TPO;甲状腺球蛋白,TG;促甲状腺激素受体,TSH-R)的患病率:已知病因组(70例,A组)和特发性组(52例,B组)。A组中有23例患者(男/女:7/16,占33%),B组中有12例患者(男/女:4/8,占23%)至少一种甲状腺抗体检测呈阳性。差异无统计学意义。A组39%的血清阳性患者和B组42%的血清阳性患者存在甲状腺疾病或血清促甲状腺激素水平改变(需要治疗)。总之,本研究表明,已知病因或特发性的CU在女性中比男性更常见,并且与甲状腺自身免疫显著相关。基于自身免疫现象是特发性CU的一种特定模式这一假设,这些结果是出乎意料的。因此,建议对所有CU患者进行甲状腺自身免疫和功能筛查,以便早期识别需要治疗潜在甲状腺功能障碍或进行随访的患者。